Last Updated : December 3, 2014
Details
FilesGeneric Name:
Ombitasvir/paritaprevir/ritonavir and dasabuvir
Project Status:
Complete
Therapeutic Area:
Hepatitis C, chronic
Manufacturer:
AbbVie Corporation
Call for patient/clinician input open:
Brand Name:
Holkira Pak
Project Line:
Reimbursement Review
Project Number:
SR0406-000
Call for patient/clinician input closed:
NOC Status at Filing:
Pre NOC
Submission Type:
Initial
Indications:
Hepatitis C, chronic
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation:
Files
Last Updated : December 3, 2014